Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.5674
-0.1323 (-18.91%)
At close: Jul 11, 2025, 4:00 PM
0.5566
-0.0108 (-1.90%)
After-hours: Jul 11, 2025, 7:59 PM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $35.17 million as of July 11, 2025. Its market cap has decreased by -50.11% in one year.
Market Cap
35.17M
Enterprise Value
19.38M
1-Year Change
-50.11%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $35.17M, a decrease of -86.28%. That is a compound annual growth rate of -41.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 35.17M | 20.72% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 701.57B |
| Johnson & Johnson | 374.02B |
| AbbVie | 339.68B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 271.96B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 229.00B |
| AstraZeneca | 223.49B |